Leonid Timashev Analyst Performance

Vice President, Biotechnology Analyst at Royal Bank Of Canada

Leonid Timashev is a stock analyst at Royal Bank Of Canada focused in the medical sector, covering 22 publicly traded companies. Over the past year, Leonid Timashev has issued 38 stock ratings, including buy and hold recommendations. While full access to Leonid Timashev's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Leonid Timashev's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Analyst Ranking

Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat

Average Return

00.00% 12-Month ROI

Success Rate

00.00% Profitable Ratings

Total Ratings

38 Last 0 Years

Buy Recommendations

86.84% 33 Buy Ratings

Companies Covered

22 Unique Companies

Ratings Distribution

Rating	Percentage	Count
Strong Buy	0.0%	0 ratings
Buy	86.8%	33 ratings
Hold	13.2%	5 ratings
Sell	0.0%	0 ratings

Out of 38 total stock ratings issued by Leonid Timashev at Royal Bank Of Canada, the majority (86.8%) have been Buy recommendations, followed by 13.2% Hold.

Best & Worst Calls

This analyst does not have any ratings with enough history to determine best and worst calls.

Exchange Coverage

Exchange	Percentage	Count
NASDAQ	77.3% of companies on NASDAQ	17 companies
NYSE	22.7% of companies on NYSE	5 companies

Leonid Timashev, an analyst at Royal Bank Of Canada, currently covers 22 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector Icon	Sector	Percentage
	Medical 21 companies	95.5%
	Consumer Staples 1 company	4.5%

Leonid Timashev of Royal Bank Of Canada specializes in stock coverage within the Medical sector, with additional focus on Consumer Staples companies.

Coverage Industries

Industry	Percentage
MED - BIOMED/GENE 16 companies	72.7%
MED - DRUGS 4 companies	18.2%
SURGICAL & MEDICAL INSTRUMENTS 1 company	4.5%
CONS PD - MISC STPL 1 company	4.5%

Leonid Timashev's Ratings History at Royal Bank Of Canada

Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe

Start Date

End Date

All Ratings Strong Buy Buy Hold Sell Rating

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription

12-Month ROIUpgrade to All Access to use the All ROI Filter

Export to Excel

Company	Report Date	Action	Report Date Price	12-Month Price Target	Rating	12-Month Price & ROI	Details
IDYA IDEAYA Biosciences	9/9/2025	Boost Price Target	$24.08	$38.00	Outperform	$0.00 00.00% ROI
JAZZ Jazz Pharmaceuticals	8/28/2025	Boost Price Target	$124.38	$151.00	Outperform	$0.00 00.00% ROI
XNCR Xencor	8/21/2025	Lower Price Target	$7.38	$15.00	Outperform	$0.00 00.00% ROI
LEGN Legend Biotech	8/12/2025	Reiterated Rating	$37.38	$77.00	Outperform	$0.00 00.00% ROI
BCYC Bicycle Therapeutics	8/11/2025	Set Price Target	$7.57	$27.00	Outperform	$0.00 00.00% ROI
INSM Insmed	8/8/2025	Boost Price Target	$109.19	$120.00	Outperform	$0.00 00.00% ROI
EWTX Edgewise Therapeutics	8/8/2025	Boost Price Target	$12.76	$49.00	Outperform	$0.00 00.00% ROI
VSTM Verastem	8/8/2025	Boost Price Target	$6.79	$13.00	Outperform	$0.00 00.00% ROI
NUVB Nuvation Bio	8/8/2025	Boost Price Target	$2.37	$7.00	Outperform	$0.00 00.00% ROI
NAMS NewAmsterdam Pharma	8/7/2025	Boost Price Target	$22.71	$39.00	Outperform	$0.00 00.00% ROI
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
ONC BeOne Medicines	8/7/2025	Boost Price Target	$296.70	$364.00	Outperform	$0.00 00.00% ROI
AXSM Axsome Therapeutics	8/5/2025	Boost Price Target	$106.54	$189.00	Outperform	$0.00 00.00% ROI
ALKS Alkermes	7/30/2025	Boost Price Target	$27.11	$42.00	Sector Perform	$0.00 00.00% ROI
EXEL Exelixis	7/29/2025	Lower Price Target	$37.20	$45.00	Sector Perform	$0.00 00.00% ROI
BCYC Bicycle Therapeutics	7/17/2025	Lower Price Target	$7.85	$25.00	Outperform	$0.00 00.00% ROI
CGON CG Oncology	7/16/2025	Lower Price Target	$25.36	$53.00	Outperform	$0.00 00.00% ROI
ONC BeOne Medicines	7/16/2025	Boost Price Target	$276.52	$349.00	Outperform	$0.00 00.00% ROI
IDYA IDEAYA Biosciences	7/9/2025	Upgrade	$21.45	$30.00		$0.00 00.00% ROI
VSTM Verastem	6/25/2025	Upgrade	$4.44	$12.00		$0.00 00.00% ROI
CRMD CorMedix	6/20/2025	Upgrade	$13.76	$17.00		$0.00 00.00% ROI
ADCT ADC Therapeutics	6/20/2025	Upgrade	$3.07	$5.00		$0.00 00.00% ROI
NUVB Nuvation Bio	6/17/2025	Upgrade	$1.79	$6.00		$0.00 00.00% ROI
AXSM Axsome Therapeutics	6/12/2025	Lower Price Target	$107.04	$186.00	Outperform	$0.00 00.00% ROI
EWTX Edgewise Therapeutics	6/5/2025	Reiterated Rating	$14.25	$48.00	Outperform	$0.00 00.00% ROI
CATX Perspective Therapeutics	6/3/2025	Upgrade	$3.21	$16.00		$0.00 00.00% ROI
BHVN Biohaven	5/19/2025	Downgrade	$16.07	$21.00	Sector Perform	$0.00 00.00% ROI
BHVN Biohaven	5/13/2025	Lower Price Target	$19.39	$54.00	Outperform	$0.00 00.00% ROI
AXSM Axsome Therapeutics	4/29/2025	Boost Price Target	$110.82	$193.00	Outperform	$0.00 00.00% ROI
EWTX Edgewise Therapeutics	4/3/2025	Lower Price Target	$12.77	$52.00	Outperform	$0.00 00.00% ROI
PYXS Pyxis Oncology	3/19/2025	Reiterated Rating	$1.07	$8.00	Outperform	$0.00 00.00% ROI
BRCC BRC	3/19/2025	Reiterated Rating	$2.12	$3.00	Buy	$0.00 00.00% ROI
ALKS Alkermes	3/13/2025	Initiated Coverage	$33.41	$40.00	Sector Perform	$0.00 00.00% ROI
BHVN Biohaven	3/4/2025	Reiterated Rating	$30.42	$61.00	Outperform	$0.00 00.00% ROI
EWTX Edgewise Therapeutics	3/4/2025	Reiterated Rating	$25.09	$56.00	Outperform	$0.00 00.00% ROI
INSM Insmed	2/25/2025	Initiated Coverage	$80.03	$100.00	Outperform	$0.00 00.00% ROI
AXSM Axsome Therapeutics	2/19/2025	Boost Price Target	$127.42	$192.00	Outperform	$0.00 00.00% ROI
NAMS NewAmsterdam Pharma	1/24/2025	Reiterated Rating	$23.67	$40.00	Outperform	$0.00 00.00% ROI
INCY Incyte	1/23/2025	Reiterated Rating	$72.24	$70.00	Sector Perform	$0.00 00.00% ROI

Stock Forecasts and Research Tools

Sign in to your free account to enjoy these benefits

• In-depth profiles and analysis for 20,000 public companies.
• Real-time analyst ratings, insider transactions, earnings data, and more.
• Our daily ratings and market update email newsletter.

Sign in to your free account to enjoy all that MarketBeat has to offer.

• Sign In
• Create Account

Your Email Address:

Email Address Required

Your Password:

Password Required

Log In

---

or

Sign in with Facebook Sign in with Google

Forgot your password?

Your Email Address:

Please enter your email address.

Please enter a valid email address

Choose a Password:

Please enter your password.

Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character.

Create My Account (Free)

---

or

Sign in with Facebook Sign in with Google

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.